TY - JOUR
T1 - Cervical Neuroendocrine Carcinoma Presenting as Isolated Large Ovarian Metastasis
T2 - A Case Report
AU - Faridzi, Ach Salman
AU - Sugianto, Grace Ariani
AU - Gumilar, Khanisyah Erza
AU - Tjokroprawiro, Brahmana Askandar
N1 - Publisher Copyright:
© 2025, International Scientific Information, Inc.. All rights reserved.
PY - 2025
Y1 - 2025
N2 - Patient: Final Diagnosis: Symptoms: Clinical Procedure: Specialty: Objective: Background: Case Report: Conclusions: Female, 42-year-old Stage IB2 cervical neuroendocrine carcinoma with ovarian metastase Abdominal pain • enlarged abdomen • weight loss Computed tomography • laboratory checkup • physical examination Obstetrics and Gynecology Rare disease Neuroendocrine carcinoma (NEC) of the cervix is rare and has high mortality and recurrence rates. The clinical symptoms of cervical NEC, such as abnormal vaginal bleeding and discharge, are similar to those of other cervical cancers. Here, we describe a case involving a 42-year-old woman with cervical NEC accompanied by an isolated large ovarian metastasis. A 42-year-old woman had experienced abdominal discomfort for the past 4 months, along with a larger abdominal circumference. Physical examination revealed a 15-cm, solid, mobile, abdominal mass and a smooth cervix. Abdominal computed tomography revealed a hypoattenuating solid mass with a calcified component and indistinct borders, measuring 16.6×15.5 cm. Tumor marker levels were as follows: cancer antigen 125, 803.9 U/mL; carcinoembryonic antigen, 241.9 ng/mL. Preoperatively, we suspected a malignant ovarian tumor without any suspicion of cervical cancer. Intraoperatively, a 25×20-cm solid mass was found on the left adnexa with peritoneal wall and rectosigmoid adhesions. We performed a total abdominal hysterectomy with bilateral salpingo-oophorectomy, followed by peritoneal biopsy and omentectomy. Histopathological examination showed a 2.5-cm endocervical mass and a normal ectocervical epithelium. Immunohistochemistry revealed a small-cell cervical NEC with metastasis to the left ovary. The final diagnosis was a stage IB2 cervical NEC with ovarian metastasis. For treatment, we administered an etoposide-cisplatin adjuvant chemotherapy regimen. NEC of the cervix can manifest as a large ovarian tumor, lack the usual indications for cervical cancer, and spread to the ovaries without metastasis to other organs.
AB - Patient: Final Diagnosis: Symptoms: Clinical Procedure: Specialty: Objective: Background: Case Report: Conclusions: Female, 42-year-old Stage IB2 cervical neuroendocrine carcinoma with ovarian metastase Abdominal pain • enlarged abdomen • weight loss Computed tomography • laboratory checkup • physical examination Obstetrics and Gynecology Rare disease Neuroendocrine carcinoma (NEC) of the cervix is rare and has high mortality and recurrence rates. The clinical symptoms of cervical NEC, such as abnormal vaginal bleeding and discharge, are similar to those of other cervical cancers. Here, we describe a case involving a 42-year-old woman with cervical NEC accompanied by an isolated large ovarian metastasis. A 42-year-old woman had experienced abdominal discomfort for the past 4 months, along with a larger abdominal circumference. Physical examination revealed a 15-cm, solid, mobile, abdominal mass and a smooth cervix. Abdominal computed tomography revealed a hypoattenuating solid mass with a calcified component and indistinct borders, measuring 16.6×15.5 cm. Tumor marker levels were as follows: cancer antigen 125, 803.9 U/mL; carcinoembryonic antigen, 241.9 ng/mL. Preoperatively, we suspected a malignant ovarian tumor without any suspicion of cervical cancer. Intraoperatively, a 25×20-cm solid mass was found on the left adnexa with peritoneal wall and rectosigmoid adhesions. We performed a total abdominal hysterectomy with bilateral salpingo-oophorectomy, followed by peritoneal biopsy and omentectomy. Histopathological examination showed a 2.5-cm endocervical mass and a normal ectocervical epithelium. Immunohistochemistry revealed a small-cell cervical NEC with metastasis to the left ovary. The final diagnosis was a stage IB2 cervical NEC with ovarian metastasis. For treatment, we administered an etoposide-cisplatin adjuvant chemotherapy regimen. NEC of the cervix can manifest as a large ovarian tumor, lack the usual indications for cervical cancer, and spread to the ovaries without metastasis to other organs.
KW - Indonesia
KW - Uterine Cervical Neoplasms
UR - http://www.scopus.com/inward/record.url?scp=85216052662&partnerID=8YFLogxK
U2 - 10.12659/AJCR.945078
DO - 10.12659/AJCR.945078
M3 - Article
C2 - 39819883
AN - SCOPUS:85216052662
SN - 1941-5923
VL - 26
JO - American Journal of Case Reports
JF - American Journal of Case Reports
M1 - e945078
ER -